LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 24 Oct 2024
Drug Safety Update

GLP

Published on 24 Oct 2024 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.